387086006: Levodopa (substance)

SNOMED CT Concept\Substance\...

\Substance categorized by disposition\Receptor agonist\Dopamine receptor agonist\Dihydroxyphenylalanine\Levodopa (substance)

\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Central nervous system agent (substance)\Antiparkinsonian agent (substance)\Dihydroxyphenylalanine\Levodopa (substance)

\Substance categorised by structure\Chemical\Chemical categorized by structure (substance)\...

\Nitrogen and/or nitrogen compound (substance)\Nitrogen compound\Organic nitrogen compound\Amine and/or amine derivative\Catecholamine and/or catecholamine derivative\Catecholamine\Dihydroxyphenylalanine\Levodopa (substance)

\Organic compound\Organic nitrogen compound\Amine and/or amine derivative\Catecholamine and/or catecholamine derivative\Catecholamine\Dihydroxyphenylalanine\Levodopa (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2003. Module: SNOMED CT core

Descriptions:

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Levodopa (substance)	Is a	Dopamine agent	false	Inferred relationship	Some
Levodopa (substance)	Is a	Dihydroxyphenylalanine	true	Inferred relationship	Some
Levodopa (substance)	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	Dopamine receptor agonist (disposition)	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Product containing levodopa (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Levodopa (substance)	Inferred relationship	Some	1
Accidental levodopa poisoning	Causative agent	False	Levodopa (substance)	Inferred relationship	Some
Intentional levodopa poisoning (disorder)	Causative agent	False	Levodopa (substance)	Inferred relationship	Some
forgiftning med levodopa, uvist med hvilken hensigt	Causative agent	False	Levodopa (substance)	Inferred relationship	Some	1
Levodopa adverse reaction	Causative agent	True	Levodopa (substance)	Inferred relationship	Some	1
Allergy to levodopa	Causative agent	False	Levodopa (substance)	Inferred relationship	Some
Levodopa overdose	Causative agent	True	Levodopa (substance)	Inferred relationship	Some	1
Accidental levodopa overdose	Causative agent	True	Levodopa (substance)	Inferred relationship	Some	1
Intentional levodopa overdose	Causative agent	True	Levodopa (substance)	Inferred relationship	Some	1
overdosis af levodopa, uvist med hvilken hensigt	Causative agent	False	Levodopa (substance)	Inferred relationship	Some	1
Levodopa 500 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levodopa (substance)	Inferred relationship	Some
carbidopa 50 mg + levodopa 200 mg tablet med modificeret udløsning	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levodopa (substance)	Inferred relationship	Some
carbidopa 10 mg + levodopa 100 mg tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levodopa (substance)	Inferred relationship	Some
carbidopa 25 mg +levodopa 100 mg tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levodopa (substance)	Inferred relationship	Some
carbidopa25 mg + levodopa 250 mg tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levodopa (substance)	Inferred relationship	Some
carbidopa 25 mg + levodopa 100 mg tablet med modificeret udløsning	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levodopa (substance)	Inferred relationship	Some
Poisoning by levodopa	Causative agent	True	Levodopa (substance)	Inferred relationship	Some	1
Product containing carbidopa and levodopa (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Levodopa (substance)	Inferred relationship	Some	1
Product containing carbidopa and entacapone and levodopa (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Levodopa (substance)	Inferred relationship	Some	2
Carbidopa 12.5 mg and entacapone 200 mg and levodopa 50 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levodopa (substance)	Inferred relationship	Some
Product containing precisely carbidopa 25 milligram and entacapone 200 milligram and levodopa 100 milligram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levodopa (substance)	Inferred relationship	Some
Product containing precisely carbidopa 37.5 milligram and entacapone 200 milligram and levodopa 150 milligram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levodopa (substance)	Inferred relationship	Some
Co-careldopa	Is a	False	Levodopa (substance)	Inferred relationship	Some
co-careldopa 12,5 mg + 50 mg tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levodopa (substance)	Inferred relationship	Some
Co-careldopa 10mg/100mg tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levodopa (substance)	Inferred relationship	Some
Co-careldopa 25mg/100mg tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levodopa (substance)	Inferred relationship	Some
Co-careldopa 25mg/250mg tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levodopa (substance)	Inferred relationship	Some
Co-careldopa 50mg/200mg m/r tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levodopa (substance)	Inferred relationship	Some
Co-careldopa 25mg/100mg m/r tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levodopa (substance)	Inferred relationship	Some
Co-careldopa	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levodopa (substance)	Inferred relationship	Some
carbidopa 10 mg + levodopa 100 mg oralt opløselig tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levodopa (substance)	Inferred relationship	Some
carbidopa 25 mg + levodopa 100 mg oralt opløselig tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levodopa (substance)	Inferred relationship	Some
carbidopa 25 mg + levodopa 250 mg oralt opløselig tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levodopa (substance)	Inferred relationship	Some
Levodopa with carbidopa	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levodopa (substance)	Inferred relationship	Some
Accidental levodopa poisoning	Causative agent	True	Levodopa (substance)	Inferred relationship	Some	1
Intentional levodopa poisoning (disorder)	Causative agent	True	Levodopa (substance)	Inferred relationship	Some	1
bivirkning af co-beneldopa	Causative agent	False	Levodopa (substance)	Inferred relationship	Some	1
bivirkning af co-careldopa	Causative agent	False	Levodopa (substance)	Inferred relationship	Some	1
allergi over for co-beneldopa	Causative agent	False	Levodopa (substance)	Inferred relationship	Some
allergi over for co-careldopa	Causative agent	False	Levodopa (substance)	Inferred relationship	Some
Product containing precisely benserazide 12.5 milligram and levodopa 50 milligram/1 each conventional release oral capsule (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levodopa (substance)	Inferred relationship	Some
Benserazide 25 mg and levodopa 100 mg oral capsule	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levodopa (substance)	Inferred relationship	Some
Product containing precisely benserazide 50 milligram and levodopa 200 milligram/1 each conventional release oral capsule (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levodopa (substance)	Inferred relationship	Some
co-beneldopa 12,5 mg/50 mg dispergibel tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levodopa (substance)	Inferred relationship	Some
co-beneldopa kapsel med modificeret udløsning a 25 mg/100 mg	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levodopa (substance)	Inferred relationship	Some
co-beneldopa 25 mg/100 mg dispergibel tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levodopa (substance)	Inferred relationship	Some
Product containing benserazide and levodopa (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Levodopa (substance)	Inferred relationship	Some	1
Product containing precisely carbidopa 25 milligram and entacapone 200 milligram and levodopa 200 milligram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levodopa (substance)	Inferred relationship	Some
Carbidopa 18.75mg + levodopa 75mg + entacapone 200mg tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levodopa (substance)	Inferred relationship	Some
Carbidopa 31.25mg + levodopa 125mg + entacapone 200mg tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levodopa (substance)	Inferred relationship	Some
Allergy to levodopa	Causative agent	True	Levodopa (substance)	Inferred relationship	Some	1
Product containing carbidopa and levodopa in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Levodopa (substance)	Inferred relationship	Some	1
co-careldopa 12,5 mg + 50 mg tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levodopa (substance)	Inferred relationship	Some	1
co-careldopa 12,5 mg + 50 mg tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Levodopa (substance)	Inferred relationship	Some	1
carbidopa 10 mg + levodopa 100 mg tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levodopa (substance)	Inferred relationship	Some	2
carbidopa 10 mg + levodopa 100 mg tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Levodopa (substance)	Inferred relationship	Some	2
carbidopa 25 mg +levodopa 100 mg tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levodopa (substance)	Inferred relationship	Some	1
carbidopa 25 mg +levodopa 100 mg tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Levodopa (substance)	Inferred relationship	Some	1
Carbidopa 12.5 mg and entacapone 200 mg and levodopa 50 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Levodopa (substance)	Inferred relationship	Some	2
Levodopa 500 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levodopa (substance)	Inferred relationship	Some	1
Levodopa 500 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Levodopa (substance)	Inferred relationship	Some	1
carbidopa 10 mg + levodopa 100 mg tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Levodopa (substance)	Inferred relationship	Some	1
Product containing precisely carbidopa 25 milligram and entacapone 200 milligram and levodopa 100 milligram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levodopa (substance)	Inferred relationship	Some	2
Product containing precisely carbidopa 25 milligram and entacapone 200 milligram and levodopa 100 milligram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Levodopa (substance)	Inferred relationship	Some	2
Product containing precisely carbidopa 25 milligram and entacapone 200 milligram and levodopa 200 milligram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levodopa (substance)	Inferred relationship	Some	2
Product containing precisely carbidopa 25 milligram and entacapone 200 milligram and levodopa 200 milligram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Levodopa (substance)	Inferred relationship	Some	2
carbidopa 25 mg +levodopa 100 mg tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Levodopa (substance)	Inferred relationship	Some	2
carbidopa25 mg + levodopa 250 mg tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levodopa (substance)	Inferred relationship	Some	2
carbidopa25 mg + levodopa 250 mg tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Levodopa (substance)	Inferred relationship	Some	2
Product containing precisely carbidopa 25 milligram and entacapone 200 milligram and levodopa 100 milligram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Levodopa (substance)	Inferred relationship	Some	1
Carbidopa 12.5 mg and entacapone 200 mg and levodopa 50 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levodopa (substance)	Inferred relationship	Some	1
Carbidopa 12.5 mg and entacapone 200 mg and levodopa 50 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Levodopa (substance)	Inferred relationship	Some	1
Product containing precisely carbidopa 37.5 milligram and entacapone 200 milligram and levodopa 150 milligram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levodopa (substance)	Inferred relationship	Some	1
Product containing precisely carbidopa 37.5 milligram and entacapone 200 milligram and levodopa 150 milligram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Levodopa (substance)	Inferred relationship	Some	1
Product containing precisely carbidopa 25 milligram and entacapone 200 milligram and levodopa 200 milligram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Levodopa (substance)	Inferred relationship	Some	3
co-careldopa 12,5 mg + 50 mg tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Levodopa (substance)	Inferred relationship	Some	2
Product containing carbidopa and levodopa in enteral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Levodopa (substance)	Inferred relationship	Some	1
Co-beneldopa 25mg/100mg prolonged-release oral capsule	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levodopa (substance)	Inferred relationship	Some
Product containing precisely carbidopa (as carbidopa monohydrate) 50 milligram and levodopa 200 milligram/1 each prolonged-release oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Levodopa (substance)	Inferred relationship	Some	2
Product containing precisely carbidopa (as carbidopa monohydrate) 50 milligram and levodopa 200 milligram/1 each prolonged-release oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Levodopa (substance)	Inferred relationship	Some	2
Product containing precisely carbidopa (as carbidopa monohydrate) 25 milligram and levodopa 100 milligram/1 each prolonged-release oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Levodopa (substance)	Inferred relationship	Some	2
Product containing precisely carbidopa (as carbidopa monohydrate) 25 milligram and levodopa 100 milligram/1 each prolonged-release oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Levodopa (substance)	Inferred relationship	Some	2
Product containing precisely carbidopa 25 milligram and entacapone 200 milligram and levodopa 100 milligram/1 each conventional release oral tablet (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Levodopa (substance)	Inferred relationship	Some	1
carbidopa 25 mg +levodopa 100 mg tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Levodopa (substance)	Inferred relationship	Some	2
carbidopa25 mg + levodopa 250 mg tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Levodopa (substance)	Inferred relationship	Some	2
Levodopa 500 mg oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Levodopa (substance)	Inferred relationship	Some	1
Product containing carbidopa and entacapone and levodopa in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Levodopa (substance)	Inferred relationship	Some	2
co-careldopa 12,5 mg + 50 mg tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Levodopa (substance)	Inferred relationship	Some	2
Product containing precisely carbidopa 25 milligram and entacapone 200 milligram and levodopa 200 milligram/1 each conventional release oral tablet (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Levodopa (substance)	Inferred relationship	Some	3
carbidopa 10 mg + levodopa 100 mg tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Levodopa (substance)	Inferred relationship	Some	1
Product containing precisely carbidopa 37.5 milligram and entacapone 200 milligram and levodopa 150 milligram/1 each conventional release oral tablet (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Levodopa (substance)	Inferred relationship	Some	1
Carbidopa 12.5 mg and entacapone 200 mg and levodopa 50 mg oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Levodopa (substance)	Inferred relationship	Some	2
allergi over for co-careldopa	Causative agent	False	Levodopa (substance)	Inferred relationship	Some	2
allergi over for co-beneldopa	Causative agent	False	Levodopa (substance)	Inferred relationship	Some	2
Product containing levodopa in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Levodopa (substance)	Inferred relationship	Some	1
Product containing only carbidopa and entacapone and levodopa (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Levodopa (substance)	Inferred relationship	Some	2
Product containing only carbidopa and levodopa (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Levodopa (substance)	Inferred relationship	Some	1
Product containing only benserazide and levodopa (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Levodopa (substance)	Inferred relationship	Some	1
Product containing only levodopa (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Levodopa (substance)	Inferred relationship	Some	1
Product containing only carbidopa and levodopa in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Levodopa (substance)	Inferred relationship	Some	1
Product containing only carbidopa and entacapone and levodopa in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Levodopa (substance)	Inferred relationship	Some	2

Page 1 of 2 End

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
1461264012	Levodopa (substance)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
1481200014	Levodopa	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
1491864012	L-3-hydroxytyrosine	en	Synonym (core metadata concept)	Active	Entire term case sensitive (core metadata concept)	SNOMED CT core
3766620018	L-dopa	en	Synonym (core metadata concept)	Active	Entire term case sensitive (core metadata concept)	SNOMED CT core
4497691000005111	Levodopa	da	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	Danish module (core metadata concept)